Results 191 to 200 of about 755,873 (344)
Serum Immuno-conglutinin in Multiple Sclerosis, Hashimoto's Disease, and Rheumatoid Arthritis [PDF]
, 1962 E.A. Caspary, Edward J. Ball
openalex +1 more source
Post‐Translational Modified Neoantigens in Autoimmune Diseases: Challenges of Immune Tolerance
Advanced Science, EarlyView.Autoimmune diseases have a high incidence and disability rate. The pathogenesis of autoimmune diseases involves the interaction among genetic factors, environmental factors, and immune disorders. The post‐translational modified neoantigens are the key nodal of these three factors. And these post‐translational modified neoantigens, after being presented
Yue Zhai +5 more
wiley +1 more source
Erratum: Developing a minimally invasive gene therapy for multiple sclerosis. [PDF]
Mol Ther Methods Clin DevNijhuis PJH +6 more
europepmc +1 more source
The association between handedness and clinicodemographic characteristics in people with multiple sclerosis: A brief report [PDF]
, 2019 Cross, Anne H +3 more
core +1 more source
FURTHER CONSIDERATIONS ON THE GEOGRAPHIC DISTRIBUTION OF MULTIPLE SCLEROSIS
, 1967 John F. Kurtzke
openalex +1 more source
Serum lipoproteins in multiple sclerosis determined by cellulose acetate electrophoresis [PDF]
, 1964 K. Gavrilescu +2 more
openalex +1 more source
Advanced Science, EarlyView.SeNSs provide a biocompatible, anti‐inflammatory UC therapy. SeNSs form protein coronas enriched with AKT/PI3K/NF‐κB pathway proteins, suppress GP130 via hydrophobic interactions, and inhibit pro‐inflammatory cytokines. In DSS‐induced UC mice, SeNSs reduce inflammation, tissue damage, and disease activity by modulating cytokine, chemokine, and ...
Dingyi Shen +5 more
wiley +1 more source
Multiple sclerosis: 2024 update. [PDF]
Free NeuropatholKlotz L, Saraste M, Airas L, Kuhlmann T.
europepmc +1 more source
AGE COHORT ANALYSIS: A METHOD OF ESTIMATING FREQUENCY CHANGES IN MULTIPLE SCLEROSIS
, 1968 Aaron Antonovsky +2 more
openalex +1 more source